Alcohol poisoning has become one of the leading preventable causes of death
the ONA take:
According to new research from the Centers for Disease Control and Prevention (CDC), six people die each day from alcohol poisoning or 2,221 people per year in the United States.
The CDC calls that figure a conservative estimate that makes it one of the leading preventable causes of death. The CDC called the population that is dying from alcohol poisoning a surprise. Rather than being college students that die from a night of binge drinking, white men between the ages of 35 and 64 die most often as a result of alcohol poisoning.
Binge drinking means consuming five or more alcoholic beverages in two to three hours for men and four or more drinks in the same period for women. Moderate consumption of alcohol, however, has some benefits, particularly on the cardiovascular system.
Moderate drinking means consuming up to two drinks per day for men and one drink per day for women. Heavy drinking has been associated with an increased risk for developing certain types of cancers, such as liver and head and neck cancer.
Six people die each day from alcohol poisoning or 2,221 people per year in the United States.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Mammograms (Fact Sheet)
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|